7. Reversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity
These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, MoclobemideSummaryTherapeutic doses of Moclobemide combined with any (S)SRI carries a significant risk of potentially fatal serotonin toxicity. This…